perampanel 0.5 MG/ML Oral Suspension [FYCOMPA]
- RxCUI
- 1790126
- RxNorm name
- perampanel 0.5 MG/ML Oral Suspension [FYCOMPA]
- Display name
- perampanel 0.5 MG/ML Oral Suspension [FYCOMPA]
- Full name
- perampanel 0.5 MG/ML Oral Suspension [FYCOMPA]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fycompa | PERAMPANEL | Catalyst Pharmaceuticals, Inc. | ec812ea3-de3a-4271-957c-db8f692d1ae3 | 2024-01-05 | Boxed warning, Warnings, Adverse reactions | 1790126 |
| Fycompa | PERAMPANEL | Eisai Inc. | 71cf3309-e182-473c-8b0b-280cabd0e122 | 2022-12-28 | Boxed warning, Warnings, Adverse reactions | 1790126 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 71cf3309-e182-473c-8b0b-280cabd0e122 | perampanel 0.5 MG/ML Oral Suspension [FYCOMPA] | SBD | 60 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) t ablets , for oral use , CIII FYCOMPA ® (perampanel) o ral s uspension , CIII Initial U.S. Approval: 20 12 | 20221228 |
| 71cf3309-e182-473c-8b0b-280cabd0e122 | Fycompa 0.5 MG in 1 mL Oral Suspension | PSN | 60 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) t ablets , for oral use , CIII FYCOMPA ® (perampanel) o ral s uspension , CIII Initial U.S. Approval: 20 12 | 20221228 |
| 71cf3309-e182-473c-8b0b-280cabd0e122 | Fycompa 0.5 MG per 1 ML Oral Suspension | SY | 60 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) t ablets , for oral use , CIII FYCOMPA ® (perampanel) o ral s uspension , CIII Initial U.S. Approval: 20 12 | 20221228 |
| ec812ea3-de3a-4271-957c-db8f692d1ae3 | Fycompa 0.5 MG per 1 ML Oral Suspension | SY | 4 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 2012 | 20240105 |
| ec812ea3-de3a-4271-957c-db8f692d1ae3 | Fycompa 0.5 MG in 1 mL Oral Suspension | PSN | 4 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 2012 | 20240105 |
| ec812ea3-de3a-4271-957c-db8f692d1ae3 | perampanel 0.5 MG/ML Oral Suspension [FYCOMPA] | SBD | 4 | These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 2012 | 20240105 |